Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ex vivo and in vivo suppression of SARS-CoV-2 with combinatorial AAV/RNAi expression vectors

14 Jan 2022

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to RNA Interference and Gene Delivery
Share to SARS-CoV-2 and COVID-19 Research
Share to Virus-based gene therapy research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 35038579
DOI: 10.1016/j.ymthe.2022.01.024

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ex vivo and in vivo suppression of SARS-CoV-2 with combinatorial AAV/RNAi expression vectorsPMID 35038579Read ↗

RNA interference as a promising treatment against SARS-CoV-2Semantic proximity Read ↗

Genome wide screen of RNAi molecules against SARS-CoV-2 creates a broadly potent prophylaxisSemantic proximity Read ↗

Production of Recombinant Adeno-Associated Virus VectorsSemantic proximity Read ↗

Production of multicopy shRNA lentiviral vectors for antiviral therapy.Semantic proximity Read ↗

Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal modelsSemantic proximity Read ↗

Novel molecular approaches to combat vectors and vector-borne viruses: Special focus on RNA interference (RNAi) mechanismsSemantic proximity Read ↗

An optimized high-throughput SARS-CoV-2 dual reporter trans-complementation system for antiviral screening in vitro and in vivoSemantic proximity Read ↗

Harnessing antiviral RNAi therapeutics for pandemic viruses: SARS-CoV-2 and HIVSemantic proximity Read ↗

Unveiling the translational and therapeutic potential of small interfering RNA molecules in combating SARS-CoV-2: A reviewSemantic proximity Read ↗

Prospects for RNAi Therapy of COVID-19Semantic proximity Read ↗

Producing high-quantity and high-quality recombinant adeno-associated virus by low-cis triple transfectionSemantic proximity Read ↗

Optimization of adeno-associated viral (AAV) gene therapies vectors for balancing efficacy, longevity and safety for clinical applicationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.